Guidelines by TG 119 are available on how to verify IMRT plans. Before any IMRT treatment begins a medical physicist should verify the actual dose being delivered to the patient. This is achieved by using a phantom with a calibrated dosimetry system or films. Chambers. It is important to know that this patient specific QA is to check on the dose calculation and delivery system 3, 4 . In general, IMRT is a complex technique including patient simulation, treatment planning, leaf sequencing, plan transfer, patient positioning, online verification and treatment delivery 5 . Typical patient-specific IMRT QA involves the measurement of a point dose and 2D dose distributions in a homogeneous phantom and compared with the treatment planning system (TPS) calculation. The whole delivery sequence of an IMRT treatment is transferred onto the CT image of the phantom and calculated with TPS. The measured and calculated planar dose distributions are compared and analyzed with dose difference, distance to agreement or gamma index, etc 6, 7 . The percentage of points, area or volume passing a pre-selected criterion is used to indicate the quality of the whole planning and delivery procedure.
Ion chamber combined with film is the early popular choice. An ion chamber could be placed in a high dose and low dose gradient region for absolute point dose measurement. Film can be irradiated to measure a relative dose distribution. An absolute planar dose map can be obtained by combining ion chamber and film measurement 8 . Accuracy of the measurement depends on the selection of the measuring point. This is a time consuming process. Film is gradually replaced by online 2D detectors such as diode arrays and ion chamber arrays. Absolute planar dose distribution could be obtained during a single delivery which makes measurement more accurate and efficient.
The gamma method, as presented by Low et al. is designed for the comparison of two dose distributions: one is defined to be the reference information (Dr (r)) (measured) and the other is queried for evaluation (Dc(r)) calculated) based on gamma criteria DD (dose difference) and DTA (distance to agreement) between measured and calculated points dose.
A recent survey shows the majority responding clinical institutions use 3%/3mm criterion in their practice. At the same time, stricter criterion such as 2%/2mm and looser criterion such as 5%/5mm are both used at different institutions. With the same comparison criterion (for example, 3%/3mm), there have been very different achievable agreements (or action levels) reported in literature 8 .
AIM of thE worK
The evaluation of gamma different methods in different intensity modulated radiotherapy cases focusing on the reasons of difference in these methods.
MAtErIAls And MEthods
2D Array seven 29 model (PTW-Freiburg Germany) the most tool used in this study. 2D detector array with 729 vented ionization chambers that operate at chamber voltage of 400v, dose rate of 500mGy/ min arranged in a 27x27 matrix. The ionization chamber is plane-parallel ionization chamber of 5mmx5mmx5mm in size of wall material made from graphite, center to center equally spacing 10mm, the ionization chamber is at 5mm from 2D array surface, and ref. Point of ions chambers is 5mm behind 2D array surface. Fig .1 shows the measuring system components of 2D array. xio treatment planning system (TPS) (Elekta CMS, Maryland Heights, MO) version 4.6.2 with step and shoot method in treatment planning and inverse planning software. The leaf sequencer used to convert an optimized fluence into a deliverable sequence of MLC segments.
Siemens Oncor impression linear accelerator (linac) this is a multi-energy machine (6 and 10 MV operating up to 500 MU/min and 6 electron energies). The MLC delivery system replaces the lower movable jaws inside the linear accelerator head. The OPTIFOCUS MLC for the ONCOR linear accelerators has 41 pairs of inner leaves with a 1.0 cm width that projected at isocenter and two pairs of outer leaves with a 0.5 cm width.
2D phantom scanning; The phantom of water equivalent polystyrene was scanned via computed tomography machine (C.T) then in exactly the same way as it used for verification process, to achieve an adequate resolution during dose calculation verification, it was essential to scanned phantom with sufficiently small slice thickness, phantom scanned with 3mm slice thickness then sent phantom slices to xio treatment planning system. Treatment planning; The clinical IMRT treatment plans were designed using xio treatment planning systems. 25 patients of different sites 14 nasopharynx, 3 maxilla and 4 thyroid and 4 prostate were used in this study, each case was planned by energy 6MV. Fig .3 show screen shot for PTV prescription dose 60 Gy of nasopharynx case with isodose lines display as colors on transverse cut .
The phantom then transferred to XIO treatment planning system via network, Each field of imrt treatment plan is transferred separately to verification phantom, all treatment parameters are the same as for real patient plan except gantry angle which is set to zero in all beams, the field isocenter is positioned at center of ion chambers of array. Fig. 6 show screen-shot from xio -TPS including IMRT QA plan QA in coronal view.
solid phantom setup on linear accelerator:
The measurement that was performed in this study were carried out with 2D array sandwiched between 2blocks of polystyrene plates 5cm back scatter below 2D array, 5cm build up above 2D array, this is the same arrangement that was designed on xio treatment planning system. The source to surface distance (SSD) was adjusted where the reference point of each chamber was 0.5 cm below 2D array surface then the reference point of measurement was 100 cm from the radiation source. in the phantom set up of measurement the gantry and collimator are set to 0, The 2d array is located on the top of package of 5cm polystyrene material, adjusted in away that the isocenter is positioned at effective point of central ion. chamber then another stack of 5cm polystyrene material is added above array, finally SSD of this arrangement should be 94.5, Fig .7 show 2Darray phantom set up on ONCOR impression linear accelerator. The set up was according to C.T scan and taken proper warm up procedure i.e 15 minutes of electronic warm up, this warm up to check 2D array response, after warm up PTW veri-software was null to ensure a proper back ground was performed to minimize electronic noise. The output of linear accelerator was measured by farmer ioniazation chamber before IMRT -QA, Each measurement 2D array must be corrected for different air pressure and temperature.
Gamma evaluation for measured and calculated plans:
To evaluate the difference between measured, calculated matrix and the matrix dose plane at chamber plane was exported to imrt matrix software to evaluate the difference between calculated matrix that come from treatment planning system (xio), the measured matrix that come from linear accelerator through verisoft programme. While RTP file is exported to QC data base of lantis record and verification system. The data can be evaluated immediately by VeriSoft software after the field has been radiated. Various evaluation algorithms are available such as the gamma index algorithm. Recording of measurement values is completely integrated in VeriSoft.
rEsults
Patient specific IMRT QA measurement for head and neck cancer (nasopharynx, thyroid, maxilla), prostate cancer have performed in this study using different methods of gamma evaluation, The difference between gamma evaluations methods have been tested by comparing global method with local method of gamma evaluation that measured using 2D array as dosimetric tool. The average difference between measured and calculated dose map in case of global method of gamma evaluation (mean) was 93.5% in nasopharynx patients, 95% in maxilla patients, 92.5% in thyroid patients, 96.5% in prostate patients & in case of local method of gamma evaluation was 69% in nasopharynx, 49% in maxilla, 67.5% in thyroid, 57% in prostate, statistical analysis for all mean was shown in fig. 8, fig. 9 , respectively. Fig.8 . Mean of gamma evaluation results using global method of evaluation in different patient.
From gamma results, it was found that the S.D in these results using global method of gamma evaluation was small with maxilla patients then increase gradually to reach moderate value with prostate, nasopharynx patients then increase sharply to reach max. Value with thyroid patients while the S.D in gamma results using local method of gamma evaluation was small with thyroid patients then increase gradually to reach moderate value with maxilla, nasopharynx patients then increase sharply to reach max. Value with prostate cases, the statistical analysis that included S.D in gamma result for each patients was shown in fig 10, fig 11, dIscussIon And conclusIon from these results it was found that:
1) In global gamma method
Gamma passing rate in one of nasopharynx patient was lager (96.4%) than another nasopharynx patient (91.8%) where no. of segments was smaller in first nasopharynx patient (106 segments) than the second nasopharynx patient (130 segments), The gamma passing rate in one of maxilla patient was larger (95.7%) than another maxilla patient (95.1%) where no. of segments was smaller in first maxilla patient (73segments) than another maxilla patient (102 segments), The gamma passing rate in one of prostate patient was larger (98.8%) than another prostate patient (96.7%) where no. of segments was smaller in first maxilla patient (73segments) than another maxilla patient (102 segments). These results were related to two main reasons.
1-Volume of PTV in nasopharynx, thyroid patients is larger than volume of PTV in prostate, maxilla patients hence no of segments increase in nasopharynx, thyroid patients than maxilla, prostate patients to fitted these increase in PTV volume.
2-When no of segments increase, the uncertainty in MLC performance increase hence uncertainty in leaf positioning increase, error in point dose of gamma matrix increase, agreement between measured and calculated matrix decrease, the gamma passing rate decrease.
3-high dose gradient near the point of measurement in high modulated head and neck plans, with this high dose gradient, set up error can attribute to large deviation of gamma results, in prostate the gamma passing rate was superior to 96.5%, this result was mainly due to the fact that the modulation of beam for prostate generate uniform dose distribution that was correlated to good passing rate.
from these results also it was found that larger variation in gamma passing rate results in nasopharynx patients (96.4%,91.85%), thyroid patients (92.7%,95.2%), small variation in gamma passing rate results in maxilla patients (95.7%,95.1%), prostate patients (96.7%,98.8%) than in maxilla patients, these variation in results were correlated to that presence of large no. of organ at risk (OAR) at near distance from PTV in nasopharynx patients, thyroid patients as parotid, cochlea and mucosa and brain stem in nasopharynx patients, larynx, esophagus in thyroid patients, presence of few no. of at near distance from PTV in maxilla, prostate patients as optic chiasm, optic nerve, brain stem in maxilla patients, as rectum, bladder in prostate patients, when organ at risk near PTV increase, this require large variation in dose gradient between PTV, organ at risk to achieve that max dose reach to PTV, less dose reach to organ at risk, this require variation in intensity map hence variation in no of segments, this lead to variation in gamma passing rate results.
2) In local gamma method
Gamma passing rate in one of nasopharynx patients was 73%, in another nasopharynx patients was 75.8%, in one of thyroid patients was 64.6%, in another thyroid patients was 64.3%, Gamma passing rate in one of maxilla patients was 47.5%, in another thyroid case patients 41.3%, Gamma passing rate in one of prostate patients was 57.7%, in another thyroid patients was 78.4%. these results were related to main reasons.
1-Volume of PTV in prostate, maxilla patients is smaller than volume of PTV in nasopharynx, thyroid patients hence no. of evaluated points in gamma matrix are smaller in prostate, maxilla than nasopharynx, thyroid patients that have large no. of evaluated point. In local method of evaluation each value of measured matrix was compared with each value of calculated matrix but without normalization relative to max. Value, hence the presence of large no. of evaluated points in measured, calculated matrix increase the ratio of passing points than failing points the same as in nasopharynx, thyroid patients, on the contrast in prostate, maxilla cases the presence of small no. of evaluated points in measured, calculated matrix decrease the ratio of passing points than failing point. 2-The presence of large variation in gamma results in one of prostate patients from another patient due to that; decrease volume of PTV, hence decrease no. of evaluated points result in that any small change in volume of PTV or OAR that surround the PTV from prostate case to another can cause large variation in no. of evaluated points, hence the ratio of passing and failing points, hence can affect on gamma results. The gamma passing rate results are better in case of gamma evaluation with global method of evaluation than in case of gamma evaluation with local method of evaluation, the no of failing points in gamma matrix is larger in case of relative method of evaluation than in case of absolute method of evaluation.
This result was correlated that; in global method of evaluation each value of measured matrix was compared with each value of calculated matrix after normalization relative to max. value in each matrix, this normalization decreases the possibility of miss matching between measured and calculated values hence gamma passing rate results increase. In local method of evaluation each value of measured matrix was compared with each value of calculated matrix but without normalization relative to max. value, absence of normalization increase the miss matching between measured and calculated values hence the gamma passing rate results decrease.
3) In prescribed (selected) dose method:
Gamma results are the same as global gamma method, this related to that max. Value that inserted in prescribed dose gamma method is the same max. value that used in global gamma method as ref. value, rest of points in gamma matrix is relative to this ref. point so prescribed gamma method give the same results as absolute gamma method.
Jin Beom Chung, Jae Sung Whan Ha and Sung-Joon Ye 2011 have been performed patient specific IMRT QA measurement for head and neck cancer, brain tumor and prostate cancer. Treatment plans were optimized with eclipse treatment planning system using a diode array as dosimetric tool. These measurement have been performed with Varian linac equipped with 120 MLC for the treatment delivery using sliding window IMRT technique and gamma criteria of 3%/ 3mm, using global method as gamma evaluation method. But this study has been investigated global and local, prescribed (selected) dose gamma evaluation methods using gamma criteria 3%/3mm, 2D ionization chamber array as dosimetric tool. Treatment plans were optimized with xio treatment planning system, siemens oncor linac were used for treatment delivery using step and shoot IMRT technique.
-Daniela Wagner, Hilke Vorwerk 2011 have been performed patient specific IMRT QA measurement for head and neck cancer and prostate cancer using 2D ionization chamber array as dosimeric tool, patient rapid arc treatment plans using gamma criteria 3%/3mm and global method gamma evaluation These measurements took place with varian linac, Treatment plans were optimized with eclipse treatment planning system. But this study has been investigated global and local, prescribed (selected) dose gamma evaluation methods. Treatment plans were optimized with xio treatment planning system, siemens oncor linac were used for treatment delivery using step and shoot IMRT technique using the same gamma criteria, 2D ionization chamer as dosimetric tool.
conclusIon
Gamma passing rate results were influenced by volume of PTV, number of segments, the range of variation in dose gradient where mean of gamma passing rate results were 93.5% in nasopharynx case with large PTV while the mean of gamma passing rate results were 96.5 % in prostate case with small PTV and standard deviation in gamma results were large in nasopharynx case 2.8 % while standard deviation in gamma results were small in prostate case 2% where variation in dose gradient was large in nasopharynx case than prostate case. The ability of 2D array to simultaneously perform global and local methods can simplify reduce IMRT work load, high dose gradient in head and neck case was related to that the modulation factor was greater due to increased complexity required to reach constrains, this was in agreement with poor gamma passing rate results.
Prostate patients have good gamma passing rate results, this was mainly due to the fact that modulation factor was smaller, simplification required to reach constrain that generate more uniform dose distribution. matrix is compared, In global method the comparison was done after normalization for each point on matrix relative to another relative value, this value is the max. Dose of ref. Value, selected dose method is the same as global method, the result of comparison depends on reference points of gamma index, comparison with global reference point pretends better gamma results than comparison with local reference point but is less sensitive in the low dose area. Where mean value of gamma results in global method of evaluation in nasopharynx, prostate were 93.5%, 96.5%, respectively, in case of local method of evaluation were 69%, 57%, respectively.
